| |
| |
|
| Insider
Information: |
Pietzke Steffen |
| Relationship: |
Chief Financial Officer |
| City: |
Incline Village |
| State: |
NV |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
774,499 |
|
|
Indirect Shares
|
20,590 |
|
|
| Direct
Value |
$6,943,889 |
|
|
|
Indirect Value
|
$50,857 |
|
|
| Total
Shares |
795,089 |
|
|
| Total
Value |
$6,994,746 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -26.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PDL Biopharma Inc |
PDLI |
VP, Finance and CAO |
2017-12-15 |
139,587 |
2017-12-15 |
20,590 |
Premium* |
|
|
Tricida, Inc. |
TCDA |
|
2018-07-02 |
10,527 |
2018-07-02 |
0 |
Premium* |
|
|
Alx Oncology Holdings Inc |
ALXO |
VP Fin & Chief Acct Of... |
2020-07-21 |
3,000 |
2020-07-21 |
0 |
Premium* |
|
|
Enovix Corp |
ENVX |
Chief Financial Officer |
2023-07-06 |
621,385 |
2021-08-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
41 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-05-10 |
4 |
D |
$13.02 |
$5,039 |
D/D |
(387) |
629,046 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-05-22 |
4 |
D |
$12.09 |
$18,401 |
D/D |
(1,522) |
627,524 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-06-06 |
4 |
D |
$13.72 |
$72,675 |
D/D |
(5,297) |
622,227 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
D |
$13.61 |
$10,643 |
D/D |
(782) |
624,655 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,210 |
625,437 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-06-10 |
4 |
D |
$13.73 |
$5,314 |
D/D |
(387) |
624,268 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-06-22 |
4 |
D |
$13.63 |
$20,745 |
D/D |
(1,522) |
622,746 |
0 |
- |
|
| ENVX |
Enovix Corp |
Chief Financial Officer |
• – – |
2023-07-06 |
4 |
D |
$18.63 |
$25,355 |
D/D |
(1,361) |
621,385 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2015-07-06 |
4 |
A |
$6.18 |
$91,143 |
D/D |
14,748 |
14,748 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2015-09-29 |
4 |
A |
$4.95 |
$9,113 |
D/D |
1,841 |
16,589 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2015-12-07 |
4 |
B |
$3.64 |
$74,931 |
I/I |
20,590 |
20,590 |
1.99 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2016-01-26 |
4 |
A |
$3.22 |
$100,255 |
D/D |
31,135 |
47,724 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2016-12-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(663) |
47,061 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
Controller and CAO |
• – – |
2017-03-04 |
4 |
A |
$2.04 |
$200,000 |
D/D |
98,039 |
145,100 |
0 |
- |
|
| PDLI |
PDL Biopharma Inc |
VP, Finance and CAO |
• – – |
2017-12-15 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,513) |
139,587 |
0 |
- |
|
| TCDA |
Tricida, Inc. |
VP Fin & Chief Acct Officer |
• • – |
2018-07-02 |
4 |
B |
$19.00 |
$200,013 |
D/D |
10,527 |
10,527 |
0.01 |
- |
|
41 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
